http://www.acc.org/Feed?clinicalTopicID=9cb8eff7-d78e-4dfc-a992-2905830cc91f Clinical Topic Feed: Pulmonary Hypertension and Venous Thromboembolism en /Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! 1793530980000 Articles and Stories /Education-and-Meetings/Patient-Case-Quizzes/2026/09/21/11/41/Escalating-Care A 55-year-old white man with resistant hypertension (HTN) and hyperlipidemia presents for routine follow-up. His current medications include olmesartan 40 mg daily, chlorthalidone 25 mg daily, spironolactone 50 mg daily, amlodipine 10 mg daily, and atorvastatin 80 mg at bedtime. 1792149060000 Educational Activities /Education-and-Meetings/Patient-Case-Quizzes/2026/09/21/11/41/Case-Challenge-Evaluating-Resistant-Hypertension A 42-year-old woman is seen in the clinic because of hypertension (HTN). She was diagnosed with HTN at 34 years of age and is currently managed on chlorthalidone 25 mg daily, telmisartan 80 mg daily, and amlodipine 5 mg daily. 1792149060000 Educational Activities /Latest-in-Cardiology/Journal-Scans/2026/10/05/20/22/Racial-Ethnic-and-Place-Based-Disparities-in-CVD-Mortality Despite sustained declines in overall cardiovascular disease mortality in the U.S., racial, ethnic and place-based disparities persist, with mortality varying far more across counties than states, according to a county-by-cause-by-population analysis published in JACC. 1791383400000 Articles and Stories /Latest-in-Cardiology/Articles/2026/09/08/14/17/HI-PEITHO-and-the-Evolution-of-Reperfusion-Strategies-in-Pulmonary-Embolism Management of intermediate-risk pulmonary embolism (PE) remains one of the most challenging areas in venous thromboembolism care. These patients are hemodynamically stable but have right ventricular (RV) dysfunction and myocardial injury, placing them at increased risk of clinical deterioration. 1788962340000 Articles and Stories /Latest-in-Cardiology/Articles/2026/09/09/13/47/eagles-eye-view-09sep2026 In this week’s View, Dr. Eagle looks at some of the important trials presented at this year’s European Society of Cardiology (ESC) Congress. 1788961680000 Articles and Stories /Latest-in-Cardiology/Articles/2026/09/01/01/JACC-in-a-Flash Featured topics and Editors' Picks from all of ACC's JACC Journals. 1788264600000 Articles and Stories /Latest-in-Cardiology/Articles/2026/08/29/08/48/sun-324am-padn-esc-2026 Pulmonary-artery denervation, in addition to guideline-directed medical therapy, resulted in fewer events of clinical worsening than medical therapy alone in patients with pulmonary hypertension associated with left heart disease and heart failure (HF), based on findings from the PADN-HF-PH trial presented at ESC Congress 2026 and simultaneously published in NEJM. 1788082020000 Articles and Stories /Latest-in-Cardiology/Articles/2026/08/24/12/30/sat-jacc-journals-esc-2026 Several abstracts and e-posters presented at ESC Congress 2026 and simultaneously published across the JACC family of journals highlight the expanding role of precision medicine, novel therapeutics, and advanced risk stratification across cardiovascular care. 1788002340000 Articles and Stories /Latest-in-Cardiology/Articles/2023/05/30/10/47/Clinical-Practice-Algorithm-For-the-Follow-Up-of-Unrepaired-and-Repaired-Ventricular-Septal-Defects Ventricular septal defects (VSDs) are the most common form of congenital heart disease (CHD) diagnosed in childhood. There is a wide variation in clinical practice for the management of common types of VSDs. 1787745480000 Articles and Stories